Open AccessCumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma
Author(s) -
Lauren E. Haydu,
Serigne Lo,
Jennifer L. McQuade,
Rodabe N. Amaria,
Jennifer A. Wargo,
Merrick I. Ross,
Janice N. Cormier,
Anthony Lucci,
Jeffrey E. Lee,
Sherise D. Ferguson,
Robyn P.M. Saw,
Andrew Spillane,
Kerwin F. Shan,
Jonathan R. Stretch,
Patrick Hwu,
Sapna Patel,
Adi Diab,
Michael K. Wong,
Isabella C. Glitza Oliva,
Hussein A. Tawbi,
Matteo S. Carlino,
Alexander M. Menzies,
Georgina V. Long,
Alexander J. Lazar,
Michael T. Tetzlaff,
Richard A. Scolyer,
Jeffrey E. Gershenwald,
John F. Thompson
Publication year - 2020
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.19.01508
Subject(s) - medicine , metastasis , melanoma , cumulative incidence , incidence (geometry) , brain metastasis , stage (stratigraphy) , oncology , cancer , primary tumor , surgery , cohort , cancer research , paleontology , physics , optics , biology
Improved understanding of the incidence, risk factors, and timing of CNS metastasis is needed to inform surveillance strategies for patients with melanoma.